Preliminary Program: Tuesday, May 22
8 a.m.-Noon
CME Courses 55-61
9 a.m.-4 p.m.
CME Courses 62-69
9 a.m.-10:30 a.m.
Component Workshops
CW23. Evaluating Competency in Psychosomatic MedicineAPA Council on Psychosomatic Medicine; Chair: Mary Jane Massie, M.D.
CW24. Culture Matters: A Multicultural Perspective on the Immigrant ExperienceAPA/AstraZeneca Minority Fellows; Chair: Alejandra Postlethwaite, M.D.
CW25. Sweet Child of Mine: Pregnancy and Parental Leave During ResidencyAPA/GlaxoSmithKline Fellows; Chair: Vishal Madaan, M.D.
CW26. The APA Web Site: Potential Future Directions and Opportunity for DialogueAPA Ad Hoc Work Group on Information Systems; Chair: Robert C. Hsiung, M.D.
CW27. Update on Psychiatry and LawAPA Council on Psychiatry and Law; Chair: Paul S. Appelbaum, M.D.
CW28. Learning Disorders Update for Mental Health ProfessionalsAPA Corresponding Committee on Mental Health and Schools; Chair: Marcia J. Slattery, M.D.
CW29. The National Health Information Network and Psychiatry: How Will Electronic Health Records Impact Our Patients and Our Practice?APA Corresponding Committee on Electronic Health Records; Chair: Farrell Hobbs Braziel, M.D.
Issue Workshops
IW28. Psychiatry in the Primary Care Setting: Making It Work for Patients and DoctorsChair: John C. Urbaitis, M.D.
IW29. The Utility of Computer-Assisted Psychoeducation for Residential Treatment of Veterans With PTSDChair: Daniella David, M.D.
IW30. How Does Culture Make a Difference in American Mental Health Care? Culturally Specific Care in Changing ContextsChair: Lawrence T. Park, M.D.
IW31. The Provider's Pursuit of Cultural Competence: A Biopsychosocial QuestChair: Richard K. Harding, M.D.
IW32. 1:1 Observation in a General Hospital Setting: Issues and RecommendationsChair: Nyapati Rao, M.D.
IW33. Recognition and Management of Neuroleptic Malignant SyndromeChair: Andrew J. Francis, M.D.
IW34. Involuntary Hospitalization of Medical Patients Who Lack Decisional Capacity: An Unresolved IssueChair: Nancy Byatt, D.O.
IW35. How to Involve Your Patients With Bipolar Disorder in Their Treatment Plan: A Guideline for CliniciansChair: Heinz Grunze, M.D.
IW36. Maintenance of Certification for Diplomates of the American Board of Psychiatry and NeurologyChair: Larry R. Faulkner, M.D.
IW37. How to Launch a Successful Private Practice: Part IChair: Martin G. Tracy, J.D.
IW38. Interpreting and Disseminating Findings From an Evidence-Based Drug Review: Antiepileptic Drugs for Mood DisordersChair: John M. Oldham, M.D.
IW39. Planned Care for Depression: A Program for the Management of Depression in Primary CareChair: Robert C. Joseph, M.D.
Lectures
L12.A. John Rush, M.D., APA's Award for Research in Psychiatry
L13.John Krystal, M.D., Distinguished Psychiatrist Lecture Series
L14.Apisamai Sriangson, M.D., International Lecture Series
Small Interactive Sessions
1. Meet the Author Jon E. Grant, M.D.
2. Meet the Author Eric Hollander, M.D.
9 a.m.-Noon
Media Workshops
MP3. When the Levees Broke: A Requiem in Four Acts By Spike Lee—The Psychiatric Dimensions of Hurricane KatrinaAPA Council on Minority Mental Health and Health Disparities; Chair: Francis G. Lu, M.D.
MP4. “Thirteen”: Parenting and Treating the Addicted TeenagerAPA Corresponding Committee on Treatment Services for Patients With Addictive Disorders; Chair: Petros Levounis, M.D.
9 a.m.-12:30 p.m.
Advances In
Advances in Assessment and Management of Suicide Robert I. Simon, M.D.
11 a.m.-12:30 p.m.
Advances in Medicine
AM02. Advances in the Cause, Treatment, and Psychology of HypertensionMichael Ziegler, M.D.
Component Workshops
CW30. Passageways: Psychological Routes to Delinquency and Therapeutic Options Out of the Juvenile Justice SystemAPA Corresponding Committeeon Juvenile Justice Issues; Chair: Camilla Lyons, M.D.
CW31. Dementia in Down Syndrome: Risk Factors, Biomarkers, Diagnosis, and TreatmentAPA Council on Aging; Chair: John M. De Figueiredo, M.D.
CW32. Spiritus Contra Spiritum: The Strange Case of Spirituality and Addiction: Discussion of the 2007 Oskar Pfister Award LectureAPA Corresponding Committee on Religion, Spirituality, and Psychiatry; Chair: George E. Vaillant, M.D.
CW33. Should the Community Replace the Asylum in the 21st Century?APA Lifers; Chair: Sheila Hafter Gray, M.D.
CW34. Novel Careers in Psychiatry: Women Who Have Made Their Own WayAPA Committee on Women; Chair: Melva I. Green, M.D.
CW35. Focusing on Asia: A Review of Disasters, Intervention, and Prevention ProgramsAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.
CW36. HIV and Metabolic SyndromeAPA Committee on AIDS; Chair: Marshall Forstein, M.D.
Issue Workshops
IW40. Second Opinion Consultation on Ongoing Psychotherapy TreatmentsChair: Mardi Horowitz, M.D.
IW41. Privacy and Confidentiality Concerns in Shared Electronic Health RecordsChair: Benjamin Liptzin, M.D.
IW42. Methamphetamine Abuse and Addiction: Prevalence and TreatmentNational Institute on Drug Abuse; Chair: Ahmed M. Elkashef, M.D.
IW43. How to Launch a Successful Private Practice: Part IIChair: William E. Callahan Jr., M.D.
IW44. Psychiatry in the Americas: Update From the World Psychiatric AssociationChair: Michelle B. Riba, M.D.
IW45. Assessing Violence Risk Among Persons With Mental IllnessesChair: Paul S. Appelbaum, M.D.
IW46. Psychiatric Expert Testimony: Increased Scrutiny, Increased LiabilityChair: Philip Merideth, M.D.
IW47. Quality of Life of Patients With Major Depression in a Natural Clinical SettingChair: Waguih William IsHak, M.D.
IW48. Are Sex Offenders Criminally Responsible?Chair: Renee M. Sorrentino, M.D.
IW49. Impact of Patient Suicide on Psychiatry Residents: A Workshop DiscussionChair: Christina Mangurian, M.D.
IW50. Physical Trauma as a Result of War or Natural Disaster: Psychiatric InterventionsChair: Geoffrey M Gabriel, M.D.
Lectures
L15. The Future of Psychiatry: International PerspectivesNorman H. Sartorius, M.D., International Lecture Series
L16. The Neurobiology of Free Will in Addictive DisordersNora Volkow, M.D., Frontiers of Science Lecture Series
L17. New Neurons in the Adult BrainFred H. Gage, Ph.D., Frontiers of Science Lecture Series
Scientific and Clinical Reports Session 10. Medical and Metabolic Consequences of Psychiatric Treatment
28. Metabolic Abnormalities in Psychiatric Inpatients John W. Goethe, M.D.
29. Neuroleptic Malignant Syndrome Induced by Low-Dose Aripiprazole in First-Episode Psychosis Harun Evcimen, M.D.
30. Metabolic Abnormalities in Patients With Major Depressive Disorders John W. Goethe, M.D.
Session 11. Access, Availability, and Utilization of Psychiatric Services
31. Recurrent Psychiatric Hospitalization William H. Sledge, M.D.
32. Reducing the Medical and Financial Burden of Depressive Illness: A Plan for Improving Health Care Services Lawrence W. Adler, M.D.
33. Psychiatric Hospital Bed Numbers and Economic Factors in the XIX and XX Centuries—New Analyses Alfonso Ceccherini-Nelli, M.D.
Session 12. International Studies in Schizophrenia
34. Brain Morphology in Schizophrenia Within the Northern Finland 1966 Birth Cohort Matti K. Isohanni, M.D.
35. The ADHES Project in Israel: New Insights in Adherence in Schizophrenia Yoram Barak, M.D.
36. Schizophrenia in the Offspring of Antenatally Depressed Mothers and Familial Risk—Follow-Up of the Northern Finland 1966 Birth Cohort Pirjo H. Maki, M.D.
Session 13. Theoretical and Research Approaches in the Study of Violence
37. Beyond the Clash of Civilizations David A. Rothstein, M.D.
38. Phases of Trauma Recovery Herbert L. Campbell, M.D.
39. Predicting Unresolved PTSS in Earthquake Survivors: A Comparison Between Decision Analysis and Logistics Regression Keng Shin Lin Sr., D.M.
Session 14. Diagnostic Issues
40. Beyond Bipolar I and II: Evidence for the Validity of the“ Softer” Bipolar Spectrum Camilo J. Ruggero, Ph.D.
41. A Proposal for a New Multiaxial Model of Psychiatric Diagnosis: A Continuum Patient Model Based on Evolutionary Developmental Gene-Environment Interaction Hoyle Leigh, M.D.
42. Improving the Understanding of Causality in Psychiatric Research Stephen B. Shanfield, M.D.
Session 15. Genetics
43. CyP Genotyping in Patients Treated for Depression Gualberto Ruano, M.D.
44. An Association Between the EPAC-1 Gene and Neuroticism and Anxiety Christel M. Middeldorp, M.D.
45. Circadian System Polymorphisms and Bipolar Disorder Daniel F. Kripke, M.D.
Session 16. Cross-Cultural Psychiatry
46. Similar Depressive Symptom Patterns in a Population-Based Study of Turkish and Moroccan Immigrants and Native Dutch Agnes Schrier
47. Prevalence and Correlates of Premenstrual Dysphoric Disorder Among Arab Primary Care Patients in the United Arab Emirates Ossama Tawakol Osman, M.D.
48. Effectiveness of Culturally Sensitive Collaborative Treatment for Treating Depressed Chinese Americans in Primary Care: A Six-Month Follow-Up Study Albert Yeung, M.D.
Session 17. Treatment of Psychiatric Disorders in Medically Ill Patients
49. Pilot Trial of Modafinil for Treatment of Depression Symptoms and Fatigue in Adult Brain-Tumor Patients Thomas A. Kaleita, Ph.D.
50. Intraoperative Cerebral Oxygen Desaturation: A Significant Risk Factor for Postoperative Delirium in Cardiac Surgery Patients Thomas S. Zaubler, M.D.
51. Mood and Anxiety Disorders in Cancer Patients: A Case Series Catherine L. Mancini, M.D.
Session 18. Evidence-Based and Guideline Approaches to Psychiatric Treatments
52. Preparing for Evidence-Based Medication-Related Psychiatric Practice: The Oregon Experience Jennifer P. Wisdom, Ph.D.
53. Improving Adherence to Treatment Guidelines in Hospitalized Patients With Bipolar Disorder Thomas E. Smith, M.D.
54. Stepped Care for Anxiety-, Depressive-, and Stress-Related Disorders: A Randomized, Controlled Trial in Primary Care and Mental Health Care Desiree Oosterbaan, Ph.D.
Small Interactive Sessions
1. Meet the Author Susan McElroy, M.D.
1 p.m.-5 p.m.
CME Courses 70-75
2 p.m.-3:30 p.m.
Lecture
L18.Jeffrey A. Lieberman, M.D., APA's Adolf Meyer Award Lecture
2 p.m.-5 p.m.
Presidential Symposia
3. Review of Geriatric Psychiatry: Current IssuesChair: Christopher C Colenda, M.D.
4. Current Research Advances: APA/NIMH/NIDA/NIAAA/NAMI PerspectivesAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.
Symposia
S27. Bullying in the Workplace: Associated Health Problems
Bullying, Basic Assumptions and Symptoms of Posttraumatic Stress Eva Mikkelsen, Ph.D. | |||||
Morbidity Associated With Workplace Bullying Among Hospital Staff Marianna Virtanen, Ph.D. | |||||
Patterns of Workplace Bullying and Psychopathology Jose Luis González de Rivera, M.D. | |||||
Psychosocial Rehabilitation of Victims of Bullying and Emotional Abuse at Work Eva Mikkelsen, Ph.D. E. Regulatory Responses to Workplace Bullying: A Global Law and Public-Policy Perspective David Yamada, J.D. | |||||
S28. New Perspectives in Psychodynamic Treatments for Borderline Personality Disorder
Mentalization: A Review of the Origins and Applications of the Concept in the Treatment of Borderline Personality Disorder Lois W. Choi-Kain, M.D. | |||||
Is Mentalization-Based Therapy More Effective Than Structured Supportive Psychotherapy for Borderline Personality Disorder—A Randomized, Controlled Trial Anthony Bateman, M.D. | |||||
To Be Announced Otto F. Kernberg, M.D. | |||||
The Role of Reflective Functioning in Affect Regulation and Psychotherapy John F. Clarkin, Ph.D. | |||||
A Psychotherapy Case Study on Alternative Perspectives John G. Gunderson, M.D. | |||||
S29. Aggressive Behavioral Disturbances in Geropsychiatric Patients
Neurobiology of Aggression Randy J. Nelson, Ph.D. | |||||
Gene-Environment Interactions and Aggression Brian C. Trainor, Ph.D. | |||||
Epidemiology of Aggressive Behaviors in Geropsychiatric Patients Nhi-Ha T. Trinh, M.D. | |||||
Evaluation and Management of Aggressive Behaviors in Geropsychiatric Patients Helen H. Kyomen, M.D. | |||||
S30. Formation of Modern Lesbian and Gay Identities: Personal, Historical, and Mental Health Perspectives
Gertrude Stein's Medical Education, Her Evolving Feminism and Lesbian Identity Gene A. Nakajima, M.D. | |||||
Superior Guinea Pig: Bryher and Psychoanalysis Maggie Magee, Psy.D. | |||||
“I Didn't Want to Be Queer”: Virgil Thomson's Adaptation to His Homosexual Identity Anthony Tommasini, D.M.A. | |||||
From the Closet to the Table: A 40-year History of Gays and APA David R. Kessler, M.D. | |||||
S31. Research Update on Adolescents With Schizophrenia: Implications for Prodromal Research
Early-Stage Neurocognitive Functioning in Adolescent Psychosis: An Examination of Illness Course and Implications for Intervention Jeffrey R. Wozniak, Ph.D. | |||||
Clozapine and Olanzapine in Refractory Early-Onset Schizophrenia: A 12-Week Randomized and Double-Blind Comparison Harvey Kranzler, M.D. | |||||
Efficacy and Tolerability of Atypical Antipsychotics in Adolescents With Psychosis Joel Oberstar, M.D. | |||||
Anomalies in White Matter Microstructure in Occipital-Temporal Pathways in Adolescents With Schizophrenia Sanjiv Kumra, M.D. | |||||
S32. Mirror Neurons, Empathy, Intuition, and Interpretation: Understanding the Minds of Others
To Be Announced Marco Iacoboni, M.D. | |||||
From Mirror Neurons to Empathy Christian Keysers, Ph.D. | |||||
How Is the Mirror Neuron Discovery Relevant to Psychoanalysis and Psychotherapy? Morris N. Eagle, Ph.D. | |||||
S33. PTSD Borderline Personality Disorder and Motherhood: Early Relations, Recognition, and Intervention
Personal and Other Terrorism Toward Women Worldwide Leah J. Dickstein, M.D. | |||||
Violence Turned Against the Victim Nada L. Stotland, M.D. | |||||
Early Interactions Between Borderline Mothers and Their Infants: Why More Intervention Could Mean Less Repetition Trauma and Distortion Gisele Apter, M.D. | |||||
The Therapeutic Use of Videotape in Working With Parents of Children With Psychiatric Disorders Alexandra M. Harrison, M.D. | |||||
S34. Uneasy Partners: The Pharmaceutical Industry and the Psychiatric Profession
The Pharmaceutical Industry, Evidence-Based Medicine, and Psychiatric Practice Howard I. Kushner, Ph.D. | |||||
Disease Mongering David Healy, M.D. | |||||
Cleaning Up Evidence-Based Med-icine David N. Osser, M.D. | |||||
Data, Dollars, and Drugs: The Dilemmas of Practice and Research Nassir Ghaemi, M.D. | |||||
Conflict of Interest in Psychiatry: How Much Disclosure Is Enough? Daniel J. Carlat, M.D. | |||||
S35. Stalking Offenders and Victims
Stalking: An Overview of the Problem Gail E. Robinson, M.D. | |||||
Stalking Victims: A Comprehensive Treatment Approach Karen M. Abrams, M.D. | |||||
The RECON Typology of Stalking J. Reid Meloy, Ph.D. | |||||
Stalking: Threat Management by Professional Cooperation Werner Tschan, M.D. | |||||
Stalking: Threat Assessment and Management Jeff Dunn | |||||
S36. Humane Aspects of Private Practice
To Be Announced Harold I. Eist, M.D. | |||||
Comprehensive Psychiatry in Private Practice, 2007 Brian Crowley, M.D. | |||||
Private Practice: The Very Model of Humane Care Ronald Abramson, M.D. | |||||
Comprehensive Psychiatry in a Community Hospital and Medical Center Provides Ready Access for Least-Restrictive Treatment John C. Urbaitis, M.D. | |||||
S37. Eating Disorders Update
Alterations of Neurocurcuits and Symptoms in Anorexia and Bulimia Nervosa Walter H. Kaye, M.D. | |||||
Epidemiology of Eating Disorders Hans W. Hoek, M.D. | |||||
Psychological Treatments of Eating Disorders: Status Quo and New Developments Ulrike Schmidt, M.D. | |||||
Pharmacological Treatment of Eating Disorders B. Timothy Walsh, M.D. | |||||
Children and Adolescents With Eating Disorders Annemarie A. van Elburg, M.D. | |||||
S38. Lumping Versus Splitting in Psychiatric Nosology
The Controversy Over Lumping vs. Splitting in Psychiatric Nosology Ahmed Okasha, M.D. | |||||
Lumping vs. Splitting: Psychopathology and the Rest of Medicine G. Scott Waterman, M.D. | |||||
Splitting in Order to Better Lump Hagop Akiskal, M.D. | |||||
Lumping in Order to Better Split Juan J. López-Ibor Jr., Ph.D. | |||||
The Need for an Eclectic Approach to the Classification of Mental Disorders Norman H. Sartorius, M.D. | |||||
S39. Choosing the Right Treatment for Substance Abuse
Cocaine Dependence: Choosing the Right Treatment Adam Bisaga, M.D. | |||||
To Be Announced David M. McDowell, M.D. | |||||
To Be Announced Frances R. Levin, M.D. | |||||
Integrating Psychosocial Interventions With Medications in the Treatment of Substance Dependence Edward V. Nunes Jr., M.D. | |||||
Choosing the Right Treatment for Opioid Dependence Herbert D. Kleber, M.D. | |||||
S40. Ethical Issues in Psychiatric Genetics
What Can Psychiatric Genetics Tell the Clinician? John R. Kelsoe, M.D. | |||||
Ethical Issues Involved in Decision Making About Genetic Testing, Disclo-sure, and Reproductive Choices Among Individauls at Risk for Huntington's Disease Robert L. Klitzman, M.D. | |||||
Disclosure of Genetic Information: Patients, Third Parties, Employers, and Insurers Paul S. Appelbaum, M.D. | |||||
Ethical Issues Related to the Use of Genetic Information in the Workplace—APA Symposium on Ethics of Psychiatric Genetics Laura W. Roberts, M.D. | |||||
Training Psychiatrists in Psychiatric Genetics: Views of Program Directors and Residents Laura B. Dunn, M.D. | |||||
S41. Women and Psychiatry Around the World: The Importance of Gender and Culture
Gender Issues in Psychiatry in Pakistan Haroon R. Chaudhry, M.D. | |||||
The African Woman in Health and Disease: Cultural Issues in the Mental Health of Women Frank G. Njenga, M.B.Ch.B. | |||||
To Be Announced Maria E. Medina-Mora, M.D. | |||||
Women and Psychiatry Around the World: The Impact of Gender and Culture in the Middle Eastern Culture Nasser F. Loza, M.D. | |||||
Changing Patterns of Self-Harm Behavior Among Women in Trinidad and Tobago: The Emergence of Self Mutilation Gerard Hutchinson, M.D. | |||||
Gender Differences in Psychiatry—A Biopsychosocial Approach From Australia Jayashri Kulkarni, M.B.B.S. | |||||
S42. Psilocybin and Psychiatry: Recent Research
Psilocybin in Late-Stage Cancer Anxiety Charles S. Grob, M.D. | |||||
Safety and Efficacy of Psilocybin in OCD Francisco A. Moreno, M.D. | |||||
Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance: 14-Month Follow-Up Roland R. Griffiths, Ph.D. | |||||
S43. How to Launch a Successful Private Practice: Part 3
Personal Factors Leading to a Successful Private Practice William E. Callahan Jr., M.D. | |||||
Office Location and Design for Efficiency and Success William E. Callahan Jr., M.D. | |||||
Streamlining Overhead and Managing your Business in Private Practice Keith W. Young, M.D. | |||||
Marketing your Unique Private Practice William E. Callahan Jr., M.D. | |||||
S44. HIV/AIDS
New Clinical Developments and Opportunities in Combating HIV Milton L. Wainberg, M.D. | |||||
The Changing Face of AIDS and HIV Disease Francine Cournos, M.D. | |||||
The Role of the Psychiatrist: Changing With the Epidemic Marshall Forstein, M.D. | |||||
The HIV and AIDS Pandemic: Changes in Populations, Perceptions, Practices, and Promises Francisco Fernandez, M.D. | |||||
S45.DSM-V:Obsessive-Compulsive–Related Disorders
Overview and Autism Eric Hollander, M.D. | |||||
OCD and the Link With Schizophrenia Joseph Zohar, M.D. | |||||
Are the Impulse Control Disorders Related to OCD? Lorrin M. Koran, M.D. | |||||
Genetics of OCD Gerald Nestadt, M.D. | |||||
Neuroimaging in Obsessive-Compulsive–Related Disorders Sanjaya Saxena, M.D. | |||||
S46. Leadership Discourse: Agents of Change in Mental Health
Overview of Agents of Change in Mental Health Transformation Yad M. Jabbarpour, M.D. | |||||
Law as an Agent of Change in the Mental Health System Paul S. Appelbaum, M.D. | |||||
Federal Perspective: Government as an Agent of Change Anita S. Everett, M.D. | |||||
How to Lose Friends and Influence People: Challenges in Transforming a State Mental Health Agency James S. Reinhard, M.D. | |||||
Research, Evidence, Practice, and Policy: New Frontiers in Realignments? Junius J. Gonzales, M.D. | |||||
S47. Depression and Anxiety: Continuous or Categorical? A View From Different Angles
Epidemiology of Mood and Anxiety Disorders in a Multicultural European City Wilco Tuinebreijer, M.D. | |||||
Is Comorbidity Between Anxiety and Depression Caused by Shared Genes? A Genome-Wide Linkage Analysis Christel M. Middeldorp, M.D. | |||||
Differential Neural Patterns in Major Depressive Disorder and Obsessive-Compulsive Disorder: An Affective Activation Neuroimaging Experiment Peter L. Remijnse, M.D. | |||||
Optimizing Treatment Strategies in Depressed Patients With Comorbid Anxiety Symptoms Henricus Van, M.D. | |||||
The Relationship Between Generalized Anxiety Disorder, Depression, and Mortality in Old Age Tjalling Jan Holwerda, III, M.D. | |||||
Managing the Patient With Comorbid Depression and an Anxiety Disorder Robert Schoevers, Ph.D. | |||||
S48. From Clinical Trials to Real-World Outcomes
Schizophrenia With Comorbid Conditions in Clinical Trials: Clinical Applicability Michael Y. Hwang, M.D. | |||||
Gaining a Better Understanding of Clinical Trial Applicability Through the Use of Outcome Measures and Adverse-Event Rating Scales Gabe Goldfeder, M.A. | |||||
Clinical Implications of Randomized Clinical Trial Designs Naveed Iqbal, M.D. | |||||
S49. Inventory of Stigmatizing Experiences
Stigma of Mental Illness: From Theory to Practice Julio E. Arboleda-Florez, Ph.D. | |||||
The Inventory of Stigma Experiences: Development and Reliability Michelle Koller, M.A. | |||||
Stigma and Discrimination in Patients With Depression and Bipolar Disorders as Captured by the Inventory of Stigmatizing Experiences Roumen V. Milev, M.D. | |||||
Stigma and Recovery Heather Stuart, Ph.D. | |||||
S50. Consumer Provider Training: Incorporating Individuals in Recovery Into the Behavioral Workforce
The University of Kansas Consumers as Providers Program: Overview of the National Award–Winning Training, Internship, and Research Program Utilizing Best Practices Diane McDiarmid, M.S.W. | |||||
To Be Announced Larry Fricks | |||||
Developing Needed Competencies to Meet Workforce Demands: The Role of Training, Supervision, and Mentoring Cheryl Gagne, Sc.D. | |||||
Adding People in Recovery to the Behavioral Health Workforce Lori Ashcraft, Psy.D. | |||||
CPSA's Recovery Support Specialist Initiative: Evaluation Results of a Consumer Provider Training Program Jason Malfait | |||||
S51. When Usual Treatments Fail: Augmentation Strategies for Refractory Schizophrenia
New Treatment of Schizophrenia by Enhancing N-Methyl-D-Aspartate Neurotransmission Guochuan E. Tsai, M.D. | |||||
Treatment-Refractory Schizophrenia: Use of High Doses of Antipsychotics Peter F. Buckley, M.D. | |||||
Natural and Alternative Treatments in Schizophrenia Richard P. Brown, M.D. | |||||
To Be Announced Joseph I. Friedman, M.D. | |||||
2 p.m.-5:30 p.m.
Advances In
Advances in Neuropsychiatry and Clinical NeurosciencesStuart C. Yudofsky, M.D.
7 p.m.-10 p.m.
Industry-Supported Symposia
IS28. Cigarette Smoking, Smoking Cessation, and Psychiatric IllnessSupported by Pfizer Inc.
What Makes Smoking Cessation Unique in Patients With a History of Depression? Alexander H. Glassman, M.D. | |||||
Pharmacological Treatment of Nicotine Dependence in Schizophrenia: The Devil Is in the Details Tony P. George, M.D. | |||||
Animal Modeling and Integrative Neurocircuitry of Addiction Vulnerability in Mental Illness Robert A. Chambers, M.D. | |||||
Pharmacotherapies for Smoking Cessation Cheryl A. Oncken, M.D. | |||||
Reward Systems Underlying Motivation and Addiction Peter W. Kalivas, Ph.D. | |||||
IS29. Am I a Psychiatrist.. .or an Endocrinologist? Coping With Metabolic Disturbances During the Treatment of SchizophreniaSupported by Pfizer and Solvay-Wyeth
Antipsychotics and Metabolic Risk: What's the Problem and What's the Solution? John W. Newcomer, M.D. | |||||
To Be Announced Robert Conley, M.D. | |||||
To Be Announced Peter F. Buckley, M.D. | |||||
To Be Announced Fred Frese, Ph.D. | |||||
IS30. Depression in the 21st Century: Keeping the Old, Adding the NewSupported by Bristol-Myers Squibb Co.
Everything you Wanted to Know About Evidence-Based Psychiatry *But Were Afraid to Ask Sharon L. Alspector, M.D. | |||||
Treatment of Mood Disorders in the 21st Century: The Best of Applied Neuroscience Charles B. Nemeroff, M.D. | |||||
Diet and MAOIs—Where We Went Wrong and Where We Need to Go Kenneth I. Shulman, M.D. | |||||
Old Friends Revisited: MAOIs—The Facts and the Myths Philip R. Muskin, M.D. | |||||
IS31. Understanding the Complexity of Bipolar Mixed EpisodesSupported by Eli Lilly and Co.
Diagnostic Dilemmas of Mixed States in Bipolar Disorder Mark A. Frye, M.D. | |||||
Comorbidity and Consequences of Bipolar Mixed Episodes Joseph F. Goldberg, M.D. | |||||
The Role of Atypical Antipsychotics in the Bipolar Mixed Episode Patient: A Risk Management Perspective Roger S. McIntyre, M.D. | |||||
Improving Long-Term Outcomes in Patients With Bipolar Mixed Episodes Lori L. Altshuler, M.D. ▪ | |||||
